Close Menu

NEW YORK (GenomeWeb) – Consumer wellness startup Onegevity Health said today that it is incorporating Gencove's low-pass genome sequencing and analytics into its service.

Under the partnership, Gencove, a spinout from the New York Genome Center, will provide its low-pass sequencing solution to Onegevity's multi-omic artificial intelligence platform and services. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

23andMe has launched a new tool that estimates someone's risk of developing severe COVID-19 if infected, Bloomberg reports.

The Guardian reports that Pasteur Institute researchers are halting their development of a SARS-CoV-2 vaccine following disappointing initial results.

The Wall Street Journal reports that an increased number of younger patients have been hospitalized as the new SARS-CoV-2 strain spread across the UK.

In Cell this week: proteomic patterns among COVID-19 affected tissue samples, transcriptome atlas of developing intestines, and more.